Skip to Content
Merck
CN

878115P

Avanti

C16-04:0 PC

Avanti Research - A Croda Brand

Synonym(s):

1-O-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C28H58NO7P
CAS Number:
Molecular Weight:
551.74
UNSPSC Code:
12352211
NACRES:
NA.25
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Product Name

C16-04:0 PC, Avanti Research - A Croda Brand 878115P, powder

assay

>99% (TLC)

form

powder

packaging

pkg of 1 × 5 mg (878115P-5mg)

manufacturer/tradename

Avanti Research - A Croda Brand 878115P

shipped in

dry ice

storage temp.

−20°C

SMILES string

[O-]P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(CCC)=O)COCCCCCCCCCCCCCCCC)=O

General description

C16-04:0 PC, also known as 1-O-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine (butanoyl-PAF), is a platelet-activating factor (PAF) analog belonging to the class of bioactive lipids. It is produced non-enzymatically in the oxidized-low density lipoprotein (Ox-LDL) particle. Butanoyl-PAF contains ether-linked hexadecyl chain at the sn-1 position and a butyryl group at the sn-2 position. It is mostly produced in body during high oxidative stress. This lipid mediator acts as a pro-inflammatory agent.

Application

C16-04:0 PC or 1-O-hexadecyl-2-butyryl-sn-glycero-3-phosphocholine is suitable to study its physicochemical properties and its association with peptides derived from the C-terminal domains of human apolipoprotein E.

Packaging

5 mL Clear Glass Sealed Ampule (878115P-5mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC


Still not finding the right product?

Explore all of our products under C16-04:0 PC


Storage Class

11 - Combustible Solids

wgk

WGK 3

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Sunil A Nankar et al.
Biochimie, 95(6), 1196-1207 (2013-02-05)
Apolipoprotein-derived peptides are promising candidates for the treatment of various inflammatory conditions and the main mechanism proposed for the protective action of these peptides includes binding to pro-inflammatory lipid mediators with high affinity and facilitating their sequestration/metabolism/clearance in the body.



Global Trade Item Number

SKUGTIN
878115P-5MG04061835353873